Even though multiple datasets we performed have analysed the role of MAP3K1 in diagnosing and predicting the outcome of glioma, further research is required to conclusively establish MAP3K1 as a new diagnostic marker and prognostic indicator for glioma. Here, MAP3K1 is linked to central nervous system cancer.